CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- 4 Open-market sale Chief Executive Officer sold 7,239 shares at $68.88 ($498,622)
- 4 Grant or award Director acquired 267 shares (grant or award)
- 4 Planned sale President sold 14,979 shares at an average $78.47 ($1,175,394)
- 4 Grant or award Director acquired 425 shares (grant or award)
- 4 Grant or award Director acquired 275 shares (grant or award)
- 4 Open-market sale President sold 81,385 shares at $62.50 ($5,086,563)
- 4 Planned sale President sold 9,692 shares at $64.00 ($620,312)
- 4 Open-market sale President sold 4,202 shares at $32.02 ($134,548)
- 4 Open-market sale Chief Financial Officer sold 877 shares at $32.02 ($28,082)
- 4 Grant or award Director acquired 533 shares (grant or award)
- 4 Grant or award Director acquired 825 shares (grant or award)
- 4 Grant or award Director acquired 517 shares (grant or award)
- 4 Planned sale Chief Financial Officer sold 8,000 shares at $38.93 ($311,440)
- 4 Open-market sale 10% owner sold 339,800 shares at an average $49.53 ($16,830,151)
- 4 Planned sale President sold 9,692 shares at $52.00 ($503,984)
- 4 Planned sale President sold 9,692 shares at $42.30 ($410,019)
- 4 Grant or award Director acquired 6,082 shares (grant or award)
- 4 Grant or award Director acquired 6,082 shares (grant or award)
- 4 Grant or award Director acquired 6,082 shares (grant or award)
- 4 Grant or award Director acquired 6,082 shares (grant or award)
Page 3 of 6 · 115 filings